Oscar Health, Inc.

OSCR Healthcare Healthcare Plans

Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024. In the quarter to June 2026, revenue grew 70.4%, EPS grew 234.8%, free cash flow grew 316.3% and total debt rose 43.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

33.79 0.22 −0.65%
Market cap
$10.4B
P/E
19.8×
Fwd P/E
29.7×
Dividend yield
—
F-score
3/9
Altman Z
1.07
Beneish M
−2.18
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
6 4 3 4

+8 more TTM periods

ROE
34.24% (2.63%) (44.38%) (22.27%)
ROA
6.25% (0.52%) (7.94%) (4.77%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(15.35%) 3.53% 35.87% 21.61%
Average Days of Receivables
18.05 26.11 18.67 17.40
Free Cash Flow per Share
14.49 9.39 4.03 2.84
Free Cash Flow
4,379.95 2,799.15 1,058.48 735.64
Capital Expenditures
(38.62) (36.14) (36.37) (34.13)
Other line items
Cash ROIC
66.74% 40.55% 25.29% 19.05%
Accounts Receivable Turnover
23.38 17.42 23.90 25.02
Accounts Payable Turnover
1.84 1.99 2.48 2.79
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
254.32 231.45 171.09 150.40
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.07) 0.47 0.01 0.02
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
15.86% 17.09% 17.52% 17.76%
Share Based Compensation of Revenue
0.49% 0.59% 0.75% 0.85%
Interest Coverage
39.73 0.62 (22.52) (8.51)
Operating CF/Net income
8.02 (71.91) (2.47) (3.15)
Depreciation/Fixed assets
0.02 0.03 0.01 0.00
Capex/Depreciation
(17.29) (14.85) (49.89) (150.35)
Revenue per Share
50.69 44.61 44.60 43.54
Operating CF per Share
14.62 9.51 4.17 2.97
Capex per Share
(0.13) (0.12) (0.14) (0.13)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates